Finally, we appraise new data identifying AITL to express a higher quantity of PD-1 and PD-L1 in both tumor cells and the surrounding immune microenvironment, along with an association of increased PD-1 and PD-L1 expression to poorer prognosis (168). This evidence concerns the gene PDCD1 and neoplasm.